One important, but less-noticed, provision in the Medicare program exempts Medicare drug plans from the "best price" policy that limits the ability of health plans and PBMs to negotiate low drug prices. Now the Bush administration is looking to drop the best price requirement for all drug purchasers.
Washington, D.C. - One important, but less-noticed, provision in the Medicare program exempts Medicare drug plans from the "best price" policy that limits the ability of health plans and PBMs to negotiate low drug prices. Now the Bush administration is looking to drop the best price requirement for all drug purchasers.
Congress added "best price" to Medicaid a decade ago to encourage pharmaceutical marketers to give Medicaid their very lowest prices. Manufacturers agreed to pay rebates to state Medicaid programs of about 15% in return for a limit on offering even lower discounts to other customers. The feds subsequently provided an exemption from best price for drugs purchased by the Veterans Administration and other government agencies, including the new Medicare program. But HMOs and hospitals have complained for years that best price prevents them from negotiating low prices for their formularies. CMS administrator Dr. Mark McClellan evidently agrees and has proposed switching to a flat rebate formula for everyone. The aim is not to curb Medicaid prescription drug spending, but to help reduce costs for the broader healthcare system.
-Jill Wechsler
HIV Antiretroviral Reduced Alzheimer’s Risk Continuously, Study Shows
May 8th 2025Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of Alzheimer’s disease by an average of 9% every year, according to new research published in Alzheimer’s and Dementia.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen